- Patent Title: Mesenchymal cell-derived exosomes to treat neurological disorders
-
Application No.: US16325445Application Date: 2017-08-14
-
Publication No.: US11129852B2Publication Date: 2021-09-28
- Inventor: Daniel Offen , Nisim Perets
- Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
- Applicant Address: IL Tel-Aviv
- Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
- Current Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
- Current Assignee Address: IL Tel-Aviv
- Agency: Browdy and Neimark, PLLC
- International Application: PCT/IL2017/050899 WO 20170814
- International Announcement: WO2018/033911 WO 20180222
- Main IPC: A61K35/28
- IPC: A61K35/28 ; A61P25/28 ; A61P25/18 ; A61K9/00 ; A61K9/127
Abstract:
A method of treating a neurological disease (such as autism) in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of microparticles derived from mesenchymal stem cells.
Public/Granted literature
- US20190209621A1 MESENCHYMAL CELL-DERIVED EXOSOMES TO TREAT NEUROLOGICAL DISORDERS Public/Granted day:2019-07-11
Information query
IPC分类:
